As the field of longevity medicine advances, the focus is shifting from merely tracking chronological age to understanding and influencing biological age. Recent developments in artificial intelligence (AI) have introduced innovative methods for estimating biological age, offering clinicians new tools to assess and potentially intervene in the aging process.
Over the past year, OpenAI has dominated headlines with ChatGPT and breakthroughs in generative AI. Now, the company has quietly entered the laboratory, and its first biological research initiative signals a profound shift in longevity science.
In collaboration with Retro Biosciences, OpenAI has developed GPT-4b micro, a specialized AI model that surpasses human capabilities in stem cell research. This venture into biological engineering marks a decisive step beyond language processing, and the results are remarkable. Early testing shows that the model achieves cellular reprogramming with 50 times greater efficiency than conventional methods, rewriting established rules of cellular biology.
A year of incredible progress, 2023 saw scientific breakthroughs abound. From revelations in epigenetic reprogramming and cellular biology to advancements in medical artificial intelligence technology, the longevity and anti-aging medicine movement forged forward at breakneck speed — and we did our best to keep pace.
So that you, valued members of our community of innovative health professionals, never missed a beat. Armed with the latest research takeaways, best practices, and breaking news, A4M Blog readers always stay ahead of the curve.
Stepping into 2024, we reflect on the monumental discoveries unlocked across the longevity landscape last year and the ones you found most captivating. We’ve gathered 2023’s most popular articles and hope you help us determine the A4M Reader’s Choice Award winner by casting your vote below! And the nominees are…
